Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,765.00    -13.00 (-0.73%)
Bid:
1,768.00
Ask:
1,771.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Director/PDMR Shareholding

30 Mar 2015 16:15

RNS Number : 8966I
Derwent London PLC
30 March 2015
 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS PERSON DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

 

1

Name of Issuer

Derwent London plc

 

2

State whether notification relates to (i) a transaction notified in accordance with DR 3.1.4R (1)(a); or (ii) DR 3.1.4R(1)(b) a disclosure made in accordance with s324 (as extended by s328) of the Companies Act 1985; or (iii) both (i) and (ii)

Notification in accordance with DR 3.1.4R (1)(a)

 

3

Name of person discharging managerial responsibilities / director

P M Williams

 

4

State whether notification relates to a person connected with a person discharging managerial responsibilities / director named in 3 and identify the connected person

Named in 3

 

5

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

Named in 3

 

6

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Ordinary 5p shares

 

7

Name of the registered shareholders and, if more than one, the number of shares held by each of them

P M Williams

 

8

State the nature of the transaction

Sale of shares distributed following deferral as part of the 2013 and 2014 annual bonus awards.

 

9

Number of shares, debentures or financial instruments relating to shares acquired

2,295

 

10

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

0.002%

 

11

Number of shares, debentures or financial instruments relating to shares disposed

2,295

 

12

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

0.002%

 

13

Price per share or value of transaction

£34.65 per share

 

14

Date and place of transaction

26 March, 2015. London.

 

15

Total holding following this notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

44,551

0.040%

 

16

Date issuer informed of transaction

27 March, 2015

 

 

If a person discharging managerial responsibilities/director has been granted options by the issuer please complete the following boxes

 

17

Date of grant

18

Period during which or date on which exercisable

19

Total amount paid (if any) for grant of the option

20

Description of shares or debentures involved (class and number)

 

 

21

Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise

 

 

22

Total number of shares or debentures over which options held following this notification

23

Any additional information

 

 

24

Name of contact and telephone number for queries

T J Kite T: 020 7659 3000

 

Name and signature of duly authorised officer of issuer responsible for making notification.

 

 

 

 

 

 

……………………………. Date of notification 30 March, 2015

T J Kite

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFESVAIIVIE
Date   Source Headline
12th Aug 20257:00 amRNSInterim Results
5th Aug 20257:00 amRNSNew headlease agreed at 50 Baker Street W1
31st Jul 20254:45 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSDisposal of Francis House SW1 for £55.5m
25th Jul 20257:00 amRNSExtension of £450m Revolving Credit Facility
30th Jun 20254:45 pmRNSTotal Voting Rights
18th Jun 20257:00 amRNSAdobe lease extension and expansion
12th Jun 202511:00 amRNSRedemption of £175 million Convertible Bonds
30th May 20254:45 pmRNSTotal Voting Rights
29th May 202511:15 amRNSHolding(s) in Company
23rd May 20254:05 pmRNS£250m 7-year 5.25% bond issuance
16th May 202512:00 pmRNSResults of 2025 Annual General Meeting
8th May 20257:00 amRNSFirst Quarter Business Update
1st May 202510:00 amRNSAnnual Bondholder Meeting
30th Apr 20254:45 pmRNSTotal Voting Rights
15th Apr 202510:00 amRNSAnnual Financial Report
9th Apr 20253:00 pmRNSAdditional Listing
31st Mar 20254:45 pmRNSTotal Voting Rights
31st Mar 202510:00 amRNSNotice of Q1 2025 Business Update
26th Mar 20251:00 pmRNSDirector/PDMR Shareholding
20th Mar 20254:45 pmRNSBlock listing Interim Review
7th Mar 20252:00 pmRNSDirector/PDMR Shareholding
4th Mar 20255:15 pmRNSDirector/PDMR Shareholding
28th Feb 20254:45 pmRNSTotal Voting Rights
27th Feb 20257:00 amRNSResults for the Year Ended 31 December 2024
31st Jan 20254:45 pmRNSTotal Voting Rights
30th Jan 20255:35 pmRNSHolding(s) in Company
27th Jan 20251:30 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNS25 Baker Street W1 offices fully pre-let
31st Dec 202412:45 pmRNSTotal Voting Rights
3rd Dec 20247:00 amRNSAcquisition
29th Nov 20244:45 pmRNSTotal Voting Rights
7th Nov 20247:00 amRNSTHIRD QUARTER BUSINESS UPDATE
5th Nov 202412:44 pmRNSHolding(s) in Company
31st Oct 20244:45 pmRNSTotal Voting Rights
23rd Oct 20245:30 pmRNSHolding(s) in Company
16th Oct 202410:30 amRNSDirectorate Change
30th Sep 20244:45 pmRNSTotal Voting Rights
20th Sep 20244:45 pmRNSBlock listing Interim Review
19th Sep 202411:00 amRNSDirector/PDMR Shareholding
17th Sep 202411:03 amRNSHolding(s) in Company
30th Aug 20244:45 pmRNSTotal Voting Rights
23rd Aug 202411:15 amRNSAdditional Listing
8th Aug 20247:00 amRNSHalf-Year Results
31st Jul 20244:45 pmRNSTotal Voting Rights
28th Jun 20244:45 pmRNSTotal Voting Rights
12th Jun 202411:00 amRNSHolding(s) in Company
10th Jun 20244:00 pmRNSDirector/PDMR Shareholding
31st May 20244:45 pmRNSTotal Voting Rights
31st May 202410:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.